The MICOR 700 System appears in FDA 510(k) records under the applicant Carl Zeiss Meditec Cataract Technologies, with a Reno, Nevada filing address. The device is regulated as a phacofragmentation system under 21 CFR 886.4670, Class II, product code HQC. Manufacturer documentation describes the MICOR 700 as a hand-held, ultrasound-free lens removal device using the ZEISS NULEX procedure. The record set covers clearances from 2025 and 2026, including a version with Auto I/A. [1][3][6][8]

Documented device and components

FDA clearance letters identify the MICOR 700 System with a drive (FG-50631), an extractor (FG-50621) and a vitrector (FG-51185), all under product code HQC. A later clearance covers MICOR 700 with Auto I/A, listing product codes HQC and MLZ. The stated intended use is fragmentation and removal of cataracts, associated irrigation and aspiration, and ancillary functions such as vitreous aspiration and cutting. [3][8]

The manufacturer datasheet lists a three-cylinder positive displacement aspiration pump with maximum vacuum of 650 mmHg, gravity-based irrigation, and a disposable handpiece with a blunt straight round tip and 2.4 mm incision size. Non-ultrasonic mechanical agitation is described as asymmetric axial tube motion, linearly variable from 0 to 40 Hz with amplitude from 0 to 170 microns. A separate disposable dual-blade 21-gauge vitrector is listed with a 5,000 cuts rate. [2]

Filing history

The 510(k) record K242801, dated June 11, 2025, names the MICOR 700 System with drive, extractor and vitrector. K243395, dated August 8, 2025, covers MICOR 700 with Auto I/A. The most recent entry, K262097, received June 22, 2026 and decided October 15, 2026, names the MICOR 700 System and MICOR 700 Extractor (FG-50621) and carries a Special clearance type with a summary statement. [3][8][1]

The supplied collection holds one linked 510(k) record, and that single record carries a substantially equivalent decision. The record sample is the same one entry, so the sample decision count matches the collection count; neither figure describes total company sales, total portfolio or safety performance. [1][5]

Applicant identity and published claims

The FDA applicant name is Carl Zeiss Meditec Cataract Technologies, with a filing address at 8740 Technology Way, Reno, Nevada. A separate October 2026 clearance for the TORUS Ultrasonic Aspirator System lists Carl Zeiss Meditec, AG as applicant, a distinct legal applicant in the same FDA listing feed. The MICOR 700 datasheet carries a Carl Zeiss Meditec Cataract Technology, Inc. address in Reno and ZEISS trademark notices. [1][5][2]

A Carl Zeiss Meditec AG press release dated September 26, 2024 states that the ZEISS MICOR 700 uses the ZEISS NULEX non-ultrasonic lens extraction procedure and was available in the U.S. That release also discloses that participating healthcare professionals have contractual or financial relationships with the company and received financial support; claims about surgical working space and operating room efficiency originate in that release. [6]

Registration and documentation scope

An FDA establishment registration and device listing result shows Carl Zeiss Meditec under registration number 3012123033. The manufacturer website for the MICOR 700 states that the international English site covers a worldwide portfolio and that featured products may not be available in the U.S., directing U.S. visitors to a country site. [7][4]